Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Shan Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1747-3854; OpenAlex author ID A5050688744. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper

Papers 4

  1. Advances in biomarkers and techniques for pancreatic cancer diagnosis. Co-author DOI 10.1186/s12935-022-02640-9↗
  2. Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics. Co-author DOI 10.1038/s41598-020-64356-y↗
  3. The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know. Co-author DOI 10.1186/s12935-020-1126-1↗
  4. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism. Last author DOI 10.1159/000494477↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sheng Tai · 4 shared papers, 2018–2022 · strength 0.45
  2. Haotian Wu · 1 shared paper, 2022 · strength 0.17
  3. Wenjia Zhou · 1 shared paper, 2020 · strength 0.09
  4. Junjie Zhao · 1 shared paper, 2020 · strength 0.09
  5. Chao Li · 1 shared paper, 2020 · strength 0.09
  6. Dehai Wu · 1 shared paper, 2018 · strength 0.08
  7. Hao Wang · 1 shared paper, 2018 · strength 0.08
  8. Lei Zhang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.